M
MiCo BioMed Co Ltd
KOSDAQ:214610
MiCo BioMed Co Ltd
KOSDAQ:214610
Price:
3 360
KRW
1.51%
Market Closed
Market Cap:
₩28.2B
Income Statement
Earnings Waterfall
MiCo BioMed Co Ltd
MiCo BioMed Co Ltd
Income Statement
MiCo BioMed Co Ltd
MiCo BioMed Co Ltd
Currency: KRW
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
694
|
391
|
371
|
489
|
575
|
1 015
|
1 453
|
1 914
|
2 425
|
2 650
|
2 900
|
3 167
|
3 175
|
2 823
|
2 371
|
1 760
|
1 133
|
955
|
1 419
|
|
| Revenue |
45 672
N/A
|
58 231
+27%
|
41 106
-29%
|
47 918
+17%
|
30 302
-37%
|
27 117
-11%
|
26 477
-2%
|
21 617
-18%
|
16 111
-25%
|
8 261
-49%
|
5 691
-31%
|
5 145
-10%
|
5 367
+4%
|
6 317
+18%
|
7 231
+14%
|
8 303
+15%
|
7 168
-14%
|
5 398
-25%
|
3 961
-27%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
(24 753)
|
(30 154)
|
(20 159)
|
(24 080)
|
(15 515)
|
(17 097)
|
(22 110)
|
(20 018)
|
(16 515)
|
(10 977)
|
(8 549)
|
(8 731)
|
(12 229)
|
(14 526)
|
(14 848)
|
(16 700)
|
(9 398)
|
(6 042)
|
(4 021)
|
|
| Gross Profit |
20 919
N/A
|
28 077
+34%
|
20 947
-25%
|
23 838
+14%
|
14 787
-38%
|
10 020
-32%
|
4 367
-56%
|
1 599
-63%
|
(403)
N/A
|
(2 716)
-573%
|
(2 857)
-5%
|
(3 586)
-26%
|
(6 861)
-91%
|
(8 209)
-20%
|
(7 617)
+7%
|
(8 396)
-10%
|
(2 230)
+73%
|
(644)
+71%
|
(60)
+91%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(17 443)
|
(23 288)
|
(22 236)
|
(28 760)
|
(25 682)
|
(26 192)
|
(27 082)
|
(27 041)
|
(25 497)
|
(23 807)
|
(18 967)
|
(15 139)
|
(12 515)
|
(14 251)
|
(15 187)
|
(16 903)
|
(11 615)
|
(9 280)
|
(8 241)
|
|
| Selling, General & Administrative |
(10 624)
|
(14 452)
|
(14 281)
|
(18 390)
|
(16 984)
|
(17 129)
|
(18 142)
|
(18 427)
|
(16 993)
|
(15 305)
|
(11 252)
|
(8 382)
|
(7 547)
|
(9 013)
|
(10 024)
|
(11 787)
|
(8 578)
|
(7 344)
|
(6 981)
|
|
| Research & Development |
(6 150)
|
(4 491)
|
(3 715)
|
(5 912)
|
(7 831)
|
(8 133)
|
(7 970)
|
(7 597)
|
(7 051)
|
(6 292)
|
(5 428)
|
(4 423)
|
(3 638)
|
(3 907)
|
(3 915)
|
(3 884)
|
(2 347)
|
0
|
(869)
|
|
| Depreciation & Amortization |
(669)
|
(871)
|
(765)
|
(983)
|
(867)
|
(929)
|
(969)
|
(1 017)
|
(1 453)
|
(1 132)
|
(1 209)
|
(1 256)
|
(1 330)
|
(1 331)
|
(1 247)
|
(1 232)
|
(690)
|
(536)
|
(409)
|
|
| Other Operating Expenses |
0
|
(3 475)
|
(3 475)
|
(3 475)
|
0
|
0
|
0
|
0
|
0
|
(1 078)
|
(1 078)
|
(1 078)
|
0
|
0
|
0
|
0
|
0
|
(1 401)
|
18
|
|
| Operating Income |
3 476
N/A
|
4 789
+38%
|
(1 289)
N/A
|
(4 922)
-282%
|
(10 895)
-121%
|
(16 172)
-48%
|
(22 715)
-40%
|
(25 442)
-12%
|
(25 900)
-2%
|
(26 523)
-2%
|
(21 824)
+18%
|
(18 725)
+14%
|
(19 376)
-3%
|
(22 460)
-16%
|
(22 803)
-2%
|
(25 300)
-11%
|
(13 845)
+45%
|
(9 924)
+28%
|
(8 301)
+16%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
(9 404)
|
(9 011)
|
8 394
|
9 195
|
53
|
(397)
|
707
|
(535)
|
(11 645)
|
(12 916)
|
(15 579)
|
(16 952)
|
(7 285)
|
(6 082)
|
(4 337)
|
(2 814)
|
(890)
|
(2 961)
|
(5 557)
|
|
| Non-Reccuring Items |
(48)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1 078)
|
0
|
0
|
0
|
(982)
|
(1 095)
|
(1 385)
|
(1 494)
|
(399)
|
(20)
|
91
|
|
| Gain/Loss on Disposition of Assets |
0
|
(1)
|
0
|
0
|
(1)
|
0
|
(215)
|
(192)
|
(192)
|
0
|
2 123
|
2 063
|
2 063
|
2 063
|
0
|
3
|
12
|
27
|
(27)
|
|
| Total Other Income |
187
|
220
|
237
|
281
|
244
|
272
|
(190)
|
(174)
|
(117)
|
(333)
|
476
|
445
|
(229)
|
692
|
(494)
|
(482)
|
(951)
|
(106)
|
232
|
|
| Pre-Tax Income |
(5 789)
N/A
|
(4 003)
+31%
|
7 342
N/A
|
4 552
-38%
|
(10 598)
N/A
|
(16 297)
-54%
|
(22 413)
-38%
|
(26 343)
-18%
|
(38 932)
-48%
|
(39 772)
-2%
|
(34 805)
+12%
|
(33 169)
+5%
|
(25 808)
+22%
|
(26 881)
-4%
|
(29 020)
-8%
|
(30 086)
-4%
|
(16 073)
+47%
|
(12 984)
+19%
|
(13 562)
-4%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
13
|
16
|
13
|
16
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
6
|
3
|
0
|
|
| Income from Continuing Operations |
(5 776)
|
(3 987)
|
7 355
|
4 568
|
(10 585)
|
(16 284)
|
(22 400)
|
(26 330)
|
(38 919)
|
(39 759)
|
(34 792)
|
(33 157)
|
(25 795)
|
(26 868)
|
(29 007)
|
(30 073)
|
(16 066)
|
(12 981)
|
(13 562)
|
|
| Income to Minority Interest |
0
|
1
|
3
|
6
|
10
|
15
|
21
|
25
|
27
|
(4)
|
(9)
|
(11)
|
21
|
55
|
57
|
65
|
20
|
13
|
0
|
|
| Net Income (Common) |
(5 776)
N/A
|
(3 986)
+31%
|
7 358
N/A
|
4 574
-38%
|
(10 575)
N/A
|
(16 269)
-54%
|
(22 378)
-38%
|
(26 305)
-18%
|
(38 893)
-48%
|
(39 764)
-2%
|
(34 801)
+12%
|
(33 168)
+5%
|
(25 774)
+22%
|
(26 814)
-4%
|
(28 950)
-8%
|
(30 008)
-4%
|
(16 046)
+47%
|
(12 968)
+19%
|
(13 562)
-5%
|
|
| EPS (Diluted) |
-2 542.35
N/A
|
-1 404.42
+45%
|
2 586.08
N/A
|
1 605.93
-38%
|
-3 716.83
N/A
|
-5 709.49
-54%
|
-7 853.65
-38%
|
-9 225.44
-17%
|
-13 644.55
-48%
|
-13 946.62
-2%
|
-12 202.08
+13%
|
-15 100.09
-24%
|
-10 415.35
+31%
|
-6 155.63
+41%
|
-6 646.06
-8%
|
-6 888.89
-4%
|
-3 116.03
+55%
|
-2 520.75
+19%
|
-1 619.03
+36%
|
|
Switch to:
Switch to:
See Also
Discover More
